ClinicalTrials.gov protocols and statistical analysis plans: a peptide research guide

01

Why the short study record is not the whole trial plan

A ClinicalTrials.gov record summarizes a study in structured fields: sponsor, design, arms, interventions, eligibility, outcomes, dates, enrollment, locations, and status. That structure helps comparison, but it cannot carry every operational or statistical detail. A peptide or GLP-1 marketing claim may cite only the title and one outcome while leaving unclear the estimand, analysis population, missing-data method, amendment history, or which version of the plan governed the result.

The protocol and SAP can fill some of those gaps. Use the NCT number to keep the documents tied to the right study. Similar development programs often contain multiple trials with related names, doses, populations, and endpoints. A protocol for one phase, product form, or population cannot automatically explain a different study, and a sponsor's master protocol can contain substudies that need separate identification.

02

What a protocol and SAP are supposed to contain

ClinicalTrials.gov defines the study protocol as the written description of the study's objectives, design, and methods; it may also include scientific background and statistical considerations. The protocol can clarify randomization, masking, visits, intervention handling, eligibility, outcome collection, safety monitoring, discontinuation, amendments, and governance that are condensed in the public fields.

The SAP is the written description of the statistical considerations for analyzing collected data. It should identify methods for each analysis, adjustments for testing multiple variables, and critical assumptions and how they are checked. In practice, researchers also look for analysis sets, treatment of missing data, intercurrent events, subgroup rules, sensitivity analyses, covariates, thresholds, and software. The exact content varies; the label SAP does not guarantee completeness.

03

Where to find study documents on ClinicalTrials.gov

Open the exact NCT record, expand all sections, and inspect More Information for study documents and links. Also check the Results tab because required protocol and SAP uploads are associated with results submission for applicable trials. ClinicalTrials.gov can label an upload Study Protocol, Statistical Analysis Plan, Informed Consent Form, or a combined protocol with SAP and/or consent form. Download the file from the registry rather than an unverified repost.

Record the document type, file name, date shown on the document, upload context, NCT number on the cover page, and whether several versions appear. Search inside the PDF for amendment, version, primary endpoint, analysis population, estimand, missing, multiplicity, sensitivity, interim, subgroup, and deviations. A scan or inaccessible PDF can make search unreliable, so verify important passages visually and preserve page references.

04

Know when absence is expected and when it is informative

ClinicalTrials.gov's FAQ explains that the final rule requires protocols and SAPs with results information for applicable clinical trials with a primary completion date on or after January 18, 2017. That statement has boundaries: not every registered study is an applicable clinical trial, not every result is yet due, and older trials have different requirements. Voluntary uploads can also appear outside the minimum requirement.

A missing document therefore does not prove concealment or noncompliance. First check the study type, primary completion date, results status, delayed-submission information, and whether summary results are posted. Look for the document in a journal supplement, sponsor repository, regulatory approval package, data-sharing portal, or publication. Describe where you searched and the date rather than declaring that no protocol exists.

05

Compare the plan with the registry, results, and paper

Build a small comparison table for the primary outcome, time point, analysis population, enrollment target, comparator, intervention, statistical test, missing-data method, multiplicity control, subgroup plan, and safety set. Compare the earliest relevant registry version, final protocol and amendments, SAP date, posted results, paper methods, supplement, and any regulatory review. Differences can be legitimate, corrected, or consequential depending on timing and explanation.

Do not use a first-versus-last comparison mechanically. Choose milestones: before enrollment, before primary completion, before database lock or unblinding when documented, at results submission, and at publication. A late clarification is not necessarily outcome switching, while an analysis added after results were visible should not be described as prespecified without support. Seek an amendment rationale and keep uncertainty near the claim.

• →NCT number
• →Protocol and amendment dates
• →SAP date
• →Primary and secondary outcomes
• →Analysis populations
• →Missing-data method
• →Multiplicity approach
• →Interim and subgroup rules
• →Results and publication match

06

Limits of document-based checking

Public protocols and SAPs can be redacted for specified personal, trade-secret, or confidential commercial information, and not every operational decision appears. Posting does not show that sites followed the protocol, data were accurate, monitoring worked, deviations were handled properly, or every analysis was reported. Conversely, an amendment does not establish bias; trials often need changes for recruitment, operations, science, safety, or regulation.

Use the documents to improve the precision of a consumer-facing statement: identify what was planned, what changed, which result was primary, and which limitations remain. Do not translate a trial plan into a treatment recommendation. Investigational status, approval, off-label use, compounding, and individual suitability are separate questions that require current regulatory records and an appropriately licensed clinician.